Abstract
Two known Clostridiodes (Clostridium) difficile surface antigens, a lipoteichoic acid (LTA) and a polysaccharide (PS-II) were isolated and purified in order to prepare glycoconjugate vaccines to the carrier protein human serum albumin utilising a reductive amination strategy. Mice and rabbits were immunized with a prime and two boost strategy and the resulting sera were examined for their ability to recognise the purified homologous antigens and subsequently killed whole cells of C. difficile strains and other Clostridia species. Immunisation derived antisera from rabbits and mice, recognised all strains of C. difficile vegetative cells examined, with generally similar titers from animals that received the LTA or the PS-II conjugates. Sera raised to the LTA conjugates were able to recognise other Clostridia species C. butyricum, C. bifermentans and C. subterminale whereas sera raised to the PS-II conjugates were not. These LTA and PS-II sera recognised live cells in an immunofluorescence assay and were also able to recognise the spore form of the bacterium. This study has confirmed that the LTA and PS-II polysaccharides are both highly conserved surface polymers of C. difficile that are easily accessible to the immune system and as such may have potential as vaccine antigens or as targets for therapeutics to combat C. difficile infection.
Similar content being viewed by others
References
Shah, D., Dang, M.-D., Hasbun, R., Koo, H.L., Jiang, Z.-D., DuPont, H.L., Garey, K.W.: Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Exp. Rev. Anti-Infect. Ther. 8, 555–564 (2010)
Mascio, C.T.M., Mortin, L.I., Howland, K.T., van Praagh, A.D.G., Zhang, S., Arya, A., Chuong, C.L., Kang, C., Li, T., Silverman, J.A.: In vitro and in vivo characterization of CB-183,315, a novel lipopeptide antibiotic for treatment of Clostridium difficile. Antimicrob. Ag. Chemother. 56, 5023–5030 (2012)
Spigaglia, P.: Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther. Adv. Inf. Dis. 3, 23–42 (2016)
Lowy, I., Molrine, D.C., Leav, B.A., Blair, B.M., Baxter, R., Gerding, D.N., Nichol, G., Thomas Jr., W.D., Leney, M., Sloan, S., Hay, C.A., Ambrosino, D.M.: Treatment with monoclonal antibodies against Clostridium difficile toxins. New Engl. J. Med. 362, 197–205 (2010)
Hussack, G., Arbabi-Ghahroudi, M., van Faassen, H., Songer, J.G., Ng, K.K.-S., MacKenzie, R., Tanha, J.: Neutralization of Clostridium difficile toxin a with single-domain antibodies targeting the cell receptor binding domain. J. Biol. Chem. 286, 8961–8976 (2011)
Farooq, P.D., Urrunaga, N.H., Tang, D.M., von Rosenvinge, E.C.: Pseudomembranous colitis. Dis. Mon. 61, 181–206 (2015)
Lawrence, B., Reddy, S.S.: Fecal microbiota transplantation for recurrent Clostridium difficile infection. J. Clin. Gastro. 45, S159–S167 (2011)
Péchiné, S., Bruxelle, J.F., Janoir, C., Collignon, A.: Targeting Clostridium difficile surface components to develop immunotherapeutic strategies against Clostridium difficile infection. Front. Micro. 9, 1009–1019 (2018)
Poxton, I.R., Ivor Cartmill, T.D.: Immunochemistry of the cell-surface carbohydrate antigens of Clostridium difficile. J. Gen. Microbiol. 128, 1365–1370 (1982)
Poxton, I.R., Byrne, M.D.: Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species. J. Gen. Microbiol. 122, 41–46 (1981)
Ganeshapillai, J., Vinogradov, E., Rousseau, J., Weese, J.S., Monteiro, M.A.: Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units. Carbohydr. Res. 343, 703–710 (2008)
Monteiro, M.A., Ma, Z., Bertolo, L., Jiao, Y., Arroyo, L., Hodgins, D., Mallozzi, M., Vedantam, G., Sagermann, M., Sundsmo, J., Chow, H.: Carbohydrate-based Clostridium difficile vaccines. Exp. Rev. Vacc. 12, 421–431 (2013)
Danieli, E., Lay, L., Proietti, P., Berti, F., Costantino, P., Adamo, R.: First synthesis of C. difficile PS-II cell wall polysaccharide repeating unit. Org. Letts. 13, 378–381 (2011)
Adamo, R., Romano, M.R., Berti, F., Leuzzi, R., Tontini, M., Danieli, E.: Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PS-II cell wall polysaccharide. ACS Chem. Biol. 7, 1420–1428 (2012)
Oberli, M.A., Hecht, M.-L., Bindschlader, P., Adibekian, A., Adam, T., Seeberger, P.H.: A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic. Chem. Biol. 18, 580–588 (2011)
Martin, C.E., Broecker, F., Oberli, M.A., Komor, J., Mattner, J., Anish, C., Seeberger, P.H.: Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. J. Am. Chem. Soc. 135, 9713–9722 (2013)
Romano, M.R., Leuzzi, R., Cappelletti, E., Tontini, M., Nilo, A., Proietti, D., Berti, F., Costantino, P., Adamo, R., Scarselli, M.: Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity. Toxins (Basel). 6(1385–1396), 1385–1396 (2014)
Monteiro, M.A.: The design of a Clostridium difficile carbohydrate-based vaccine. Methods Mol. Biol. 1403, 397–408 (2016)
Bertolo, L., Boncheff, A.G., Ma, Z., Chen, Y.H., Wakeford, T., Friendship, R.M., Rosseau, J., Weese, J.S., Chu, M., Mallozzi, M., Vedantam, G., Monteiro, M.A.: Clostridium difficile carbohydrates: Glucan in spores, PSII common antigen in cells, immunogenicity of PSII in swine and synthesis of a dual C. difficile-ETEC conjugate vaccine. Carbohydr. Res. 354, 79–86 (2012)
Reid, C.W., Vinogradov, E., Li, J., Jarrell, H.C., Logan, S.M., Brisson, J.-R.: Structural characterization of surface glycans from Clostridium difficile. Carbohydr. Res. 354, 65–73 (2012)
Cox, A.D., St. Michael, F., Aubry, A., Cairns, C., Strong, P., Hayes, A., Logan, S.M.: Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile. Glycoconj. J. 30, 843–855 (2013)
Martin, C.E., Broecker, F., Eller, S., Oberli, M.A., Anish, C., Pereira, C.L., Seeberger, P.H.: Glycan arrays containing Clostridium difficile lipoteichoic acid oligomers as tools towards a carbohydrate vaccine. Chem. Comm (Camb.). 49, 7159–7161 (2013)
Broecker, F., Hanske, J., Martin, C.E., Baek, J.Y., Wahlbrink, A., Wojcik, F., Hartmann, L., Rademacher, C., Anish, C., Seeberger, P.H.: Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nat. Commun. 7, 11224–11235 (2016)
Broecker, F., Martin, C.E., Wegner, E., Mattner, J., Baek, J.Y., Pereira, C.L., Anish, C., Seeberger, P.H.: Synthetic lipoteichoic acid glycans are potential vaccine candidates to protect from Clostridium difficile infections. Chem. Cell. Biol. 23, 1014–1022 (2016)
Broecker, F., Wegner, E., Seco, B.M.S., Kaplonek, P., Bräutigam, M., Ensser, A., Pfister, F., Daniel, C., Martin, C.E., Mattner, J., Seeberger, P.H.: Synthetic oligosaccharide-based vaccines protect mice from Clostridioides difficile infections. ACS Chem. Biol. 14, 2720–2728 (2019)
Chu, M., Mallozzi, M.J.G., Roxas, B.P. Bertolo,L., Monteiro, M.A., Agellon, A., Viswanathan, V.K., Vedantam, G.: A Clostridium difficile cell wall glycopolymer locus influences bacterial shape, polysaccharide production and virulence. PLoS Pathog. (2016) https://doi.org/10.1371/journal.ppat.1005946, 12, e1005946
Leuzzi, R., Adamo, R., Scarselli, M.: Vaccines against Clostridium difficile. Hum. Vaccin. Immunother. 10, 1466–1477 (2014)
Laemmli, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227, 680–685 (1970)
St. Michael, F., Yang, Q., Cairns, C., Vinogradov, E., Hayes, A.C., Aubry, A., Cox, A.D.: Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans. Glycoconj. J. 35, 53–64 (2018)
Rappuoli, R., et al.: Sci. Transl. Med. 10, eaat4615 (2018)
Wenzel, C.Q., Mills, D.C., Dobruchowska, J.M., Vlach, J., Nothaft, H., Nation, P., Azadi, P., Melville, S.B., Carlson, R.W., Feldman, M.F., Szymanski, C.M.: An atypical lipoteichoic acid from Clostridium perfringens elicits a broadly cross-reactive and protective immune response. J. Biol. Chem. https://doi.org/10.1074/jbc.RA119.009978
Kimbrell, M.R., Warshakoon, H., Cromer, J.R., Malladi, S., Hood, J.D., Balakrishna, R., Scholdberg, T.A., David, S.A.: Comparison of the immunostimulatory and proinflammatory activities of candidate gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol. Lett. 118, 132–141 (2008)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest/competing interests
None to declare.
Ethics approval
All animal work follows NRC’s Human Health Therapeutics Research Centre’s animal care committee approved procedures that fall under the Canadian Council of Animal Care jurisdiction.
Consent to participate
Not applicable.
Consent for publication
All authors have consented to publish this material.
Availability of data and material
All data has been disclosed.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the Topical Collection: Glycoconjugate vaccines: classic and novel approaches
Rights and permissions
About this article
Cite this article
Cox, A., St. Michael, F., Aubry, A. et al. Comparison of polysaccharide glycoconjugates as candidate vaccines to combat Clostridiodes (Clostridium) difficile. Glycoconj J 38, 493–508 (2021). https://doi.org/10.1007/s10719-020-09937-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-020-09937-9